Guerra Pan Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$500K Buy
403
+26
+7% +$30.7K 0.28% 64
2026
Q2
$452K Buy
377
+3
+0.8% +$3.06K 0.25% 70
2026
Q1
$344K Hold
374
– – 0.21% 81
2025
Q4
$402K Hold
374
– – 0.24% 76
2025
Q3
$285K Hold
374
– – 0.17% 91
2025
Q2
$292K Hold
374
– – 0.19% 89
2025
Q1
$309K Hold
374
– – 0.24% 81
2024
Q4
$289K Hold
374
– – 0.21% 89
2024
Q3
$331K Buy
374
+9
+2% +$8.09K 0.27% 80
2024
Q2
$330K Buy
+365
New +$292K 0.28% 78

Other funds holding LLY

Guerra Pan Advisors's LLY Position: Q3 2026 in Review

Guerra Pan Advisors increased its Eli Lilly (LLY) stake by 6.9% in Q3 2026, buying an estimated $30.7K and bringing the position to 403 shares worth $500K. The position accounts for 0.28% of the portfolio, ranked #64.

Guerra Pan Advisors first reported a position in LLY in Q2 2024 and has held it in 10 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Guerra Pan Advisors held 403 shares of Eli Lilly worth $500K as of Q3 2026.
  • Guerra Pan Advisors bought 26 Eli Lilly shares in Q3 2026, an estimated $30.7K.
  • Eli Lilly made up 0.28% of Guerra Pan Advisors's portfolio in Q3 2026, its #64 holding.
  • Guerra Pan Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 10 quarters since.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Guerra Pan Advisors's 13F filing for Q3 2026, filed 26 Oct 2026.